Comparable stake leader
Joshua S. Boger
SEC ownership of CervoMed Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001053691.
Disclosed value leader
John J. Alam
Comparable rows
41/50
Latest evidence
30 Jun 2026
- Public ticker
- CRVO on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Joshua S. Boger
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
41 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Joshua S. Boger
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001053691
- Issuer location
- Boston, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CervoMed Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Joshua S. Boger
Disclosed value leader
John J. Alam
Comparable rows
41/50
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
9 rows are not safely comparable across share classes.
13D/G row: Joshua S. Boger
Showing 1-8 of 50 holder rows.
Quick read
Joshua S. Boger leads the comparable SEC ownership view at 20%.
41 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Joshua S. Boger's linked filing trail.
Comparable ownership
Top 5
Joshua S. Boger
20%
ARMISTICE CAPITAL, LLC
9.5%
RA CAPITAL MANAGEMENT, L.P.
8.6%
Woodline Partners LP
5.1%
AWM Investment Company, Inc.
4.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Joshua S. Boger |
13D/G
3/4/5
BOGER JOSHUA S · Director, 10%+ Owner
|
20%
|
$8,309,619
2,204,143 shares
|
$0 | 11 Jun 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
9.5%
|
$5,686,521
1,592,863 shares
|
$0 | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
8.6%
|
$4,520,131
1,266,143 shares
|
+$853,965 | 30 Jun 2026 |
| Woodline Partners LP |
13D/G
13F
Company
|
5.1%
|
$2,459,684
688,987 shares
|
$0 | 30 Jun 2026 |
| AWM Investment Company, Inc. |
13D/G
|
4.2%
|
$1,596,350
405,165 shares
|
-$1,804,658 | 31 Mar 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
0.1%
from 13D/G
|
$39,367
12,699 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
1.9%
|
$980,226
316,202 shares
|
— | 30 Jun 2026 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
1.5%
|
$771,528
248,880 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$3,737,723.
Buys
$3,737,723
Insiders: 5
Sells
$0
Insiders: 0
Net
+$3,737,723
Shares: +1,047,414
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 1,047,414
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 955,414 | 0 | $3,000,000 | $0 | +$3,000,000 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 92,000 | 0 | $737,723 | $0 | +$737,723 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to CervoMed Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Largest Forms 3/4/5 holder
Sylvie Gregoire
Net 12M change
+$3,737,724
Latest report
11 Jun 2026
Recent insider transactions for CervoMed Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Joshua S. Boger | CRVO | Common Stock | Purchase | 113.7% | $3,000,000 | $3.14 | 955,414 | 1,795,865 | 11 Jun 2026 | By Trusts |
| Joshua S. Boger | CRVO | Series C Warrants | Purchase | 955,414 | 955,414 | 11 Jun 2026 | By Trust | |||
| Joshua S. Boger | CRVO | Series B Warrants | Purchase | 955,414 | 955,414 | 11 Jun 2026 | By Trust | |||
| Frank Zavrl | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| Marwan Sabbagh | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| David Quigley | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| Jeffrey Poulton V | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| Jane H. Hollingsworth | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| Sylvie Gregoire | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| Joshua S. Boger | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | Direct | |||
| John J. Alam | CRVO | Stock Option (Right to Buy) | Award | 8,150 | 8,150 | 08 Jun 2026 | By Spouse | |||
| Matthew Winton | CRVO | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 11 Feb 2026 | Direct | |||
| Sylvie Gregoire | CRVO | Stock Option (Right to Buy) | Award | 75,000 | 75,000 | 11 Feb 2026 | By Spouse | |||
| William R. Elder | CRVO | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 11 Feb 2026 | Direct | |||
| Mark de Rosch | CRVO | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 11 Feb 2026 | Direct | |||
| Kelly Blackburn | CRVO | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 11 Feb 2026 | Direct | |||
| John J. Alam | CRVO | Stock Option (Right to Buy) | Award | 75,000 | 75,000 | 11 Feb 2026 | Direct | |||
| Matthew Winton | CRVO | Common Stock | Purchase | 11.1% | $11,925 | $7.95 | 1,500 | 15,000 | 18 Nov 2025 | Direct |
| William R. Elder | CRVO | Common Stock | Purchase | 25% | $20,800 | $8.32 | 2,500 | 12,500 | 18 Nov 2025 | Direct |
| Matthew Winton | CRVO | Common Stock | Purchase | 35% | $29,505 | $8.43 | 3,500 | 13,500 | 17 Nov 2025 | Direct |
| Sylvie Gregoire | CRVO | Common Stock | Purchase | 638.3% | $91,427 | $8.46 | 10,807 | 12,500 | 17 Nov 2025 | Spouse's IRA |
| Sylvie Gregoire | CRVO | Common Stock | Purchase | 0.73% | $91,309 | $8.46 | 10,793 | 1,484,078 | 17 Nov 2025 | Direct |
| William R. Elder | CRVO | Common Stock | Purchase | 11.1% | $8,450 | $8.45 | 1,000 | 10,000 | 17 Nov 2025 | Direct |
| John J. Alam | CRVO | Common Stock | Purchase | 632.3% | $91,309 | $8.46 | 10,793 | 12,500 | 17 Nov 2025 | Spouse's IRA |
| John J. Alam | CRVO | Common Stock | Purchase | 0.73% | $91,427 | $8.46 | 10,807 | 1,484,078 | 17 Nov 2025 | Direct |
| Sylvie Gregoire | CRVO | Common Stock | Purchase | $12,782 | $7.55 | 1,693 | 1,693 | 14 Nov 2025 | Spouse's IRA | |
| Sylvie Gregoire | CRVO | Common Stock | Purchase | 0.12% | $12,922 | $7.57 | 1,707 | 1,473,285 | 14 Nov 2025 | Direct |
| John J. Alam | CRVO | Common Stock | Purchase | $12,922 | $7.57 | 1,707 | 1,707 | 14 Nov 2025 | Spouse's IRA | |
| John J. Alam | CRVO | Common Stock | Purchase | 0.12% | $12,782 | $7.55 | 1,693 | 1,473,271 | 14 Nov 2025 | Direct |
| Matthew Winton | CRVO | Common Stock | Purchase | $75,700 | $7.57 | 10,000 | 10,000 | 14 Nov 2025 | Direct | |
| Sylvie Gregoire | CRVO | Common Stock | Purchase | 0.3% | $33,397 | $7.51 | 4,447 | 1,471,578 | 13 Nov 2025 | Direct |
| John J. Alam | CRVO | Common Stock | Purchase | 0.3% | $33,397 | $7.51 | 4,447 | 1,471,578 | 13 Nov 2025 | Direct |
| Sylvie Gregoire | CRVO | Common Stock | Purchase | 0.38% | $40,815 | $7.35 | 5,553 | 1,467,131 | 12 Nov 2025 | Direct |
| William R. Elder | CRVO | Common Stock | Purchase | 63.6% | $26,040 | $7.44 | 3,500 | 9,000 | 12 Nov 2025 | Direct |
| John J. Alam | CRVO | Common Stock | Purchase | 0.38% | $40,815 | $7.35 | 5,553 | 1,467,131 | 12 Nov 2025 | Direct |
| David Quigley | CRVO | Stock Option (Right to Buy) | Award | 16,200 | 16,200 | 27 Oct 2025 | Direct | |||
| Matthew Winton | CRVO | Stock Option (Right to Buy) | Award | 75,000 | 75,000 | 06 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.